Medicare Enrolled
Dr. Loan Retchless, NP
Nurse Practitioner - Family · Tacoma, WA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Retchless from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Retchless?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Retchless
Dr. Loan Retchless is a nurse practitioner - family in Tacoma, WA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Retchless performed 652 Medicare services across 322 unique beneficiaries.
Between the years covered by Open Payments, Dr. Retchless received a total of $20,172 from 81 pharmaceutical and/or device companies across 883 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Retchless is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 15% volume in WA
$20,172 industry payments
Medicare Practice Summary
Medicare Utilization ↗652
Medicare services
Top 15% in WA for nurse practitioner - family
322
Unique beneficiaries
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~33 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
223 | $79 | $390 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
145 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
115 | $8 | $9 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
61 | $10 | $39 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
59 | $9 | $67 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
32 | $48 | $277 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
17 | $88 | $421 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.6% high complexity
9.0% medium
88.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$20,172
Total received (2021-2024)
Avg $5,043/year across 4 years
Top 1% in WA for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
81
Companies
883
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,945 (84.0%)
Other
Charitable contributions, space rental, and other categories
$2,067 (10.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,160 (5.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,891
2023
$5,732
2022
$5,212
2021
$5,338
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$569
Novartis Pharmaceuticals Corporation
$283
PFIZER INC.
$243
TAIHO ONCOLOGY, INC.
$231
Merck Sharp & Dohme LLC
$220
GlaxoSmithKline, LLC.
$179
SOBI, INC
$178
ADC Therapeutics America, Inc.
$151
Astellas Pharma US Inc
$147
E.R. Squibb & Sons, L.L.C.
$141
Incyte Corporation
$139
Regeneron Healthcare Solutions, Inc.
$119
Celgene Corporation
$110
Genmab U.S., Inc.
$95
Lilly USA, LLC
$88
Janssen Biotech, Inc.
$68
Daiichi Sankyo Inc.
$64
ARRAY BIOPHARMA INC
$64
BeiGene USA, Inc.
$62
Boehringer Ingelheim Pharmaceuticals, Inc.
$61
TerSera Therapeutics LLC
$58
Ipsen Biopharmaceuticals, Inc
$57
Bayer Healthcare Pharmaceuticals Inc.
$57
Eisai Inc.
$55
Takeda Pharmaceuticals U.S.A., Inc.
$50
Tempus AI, Inc
$50
Acrotech Biopharma Inc.
$50
Pharmacosmos Therapeutics Inc.
$47
Exelixis Inc.
$35
SpringWorks Therapeutics, Inc.
$30
Apellis Pharmaceuticals, Inc.
$29
Organon Llc
$25
Aveo Pharmaceuticals, Inc.
$23
ACCORD HEALTHCARE, INC.
$22
EMD Serono, Inc.
$19
Octapharma USA, Inc.
$17
Mirati Therapeutics, Inc.
$15
ABBVIE INC.
$14
Gilead Sciences, Inc.
$14
Rigel Pharmaceuticals, Inc.
$13
Top 3 companies account for 28.1% of 2024 payments
All-time payments by company (2021-2024) ›
Novartis Pharmaceuticals Corporation
$2,316
AstraZeneca Pharmaceuticals LP
$1,683
E.R. Squibb & Sons, L.L.C.
$1,431
Astellas Pharma US Inc
$1,406
Seagen Inc.
$941
PFIZER INC.
$783
Lilly USA, LLC
$760
Celgene Corporation
$678
Amgen Inc.
$675
Merck Sharp & Dohme LLC
$559
Janssen Biotech, Inc.
$505
Incyte Corporation
$491
Boehringer Ingelheim Pharmaceuticals, Inc.
$429
Pharmacyclics LLC, An AbbVie Company
$420
Daiichi Sankyo Inc.
$381
Bayer HealthCare Pharmaceuticals Inc.
$366
Regeneron Healthcare Solutions, Inc.
$312
BeiGene USA, Inc.
$301
TerSera Therapeutics LLC
$297
GlaxoSmithKline, LLC.
$287
Takeda Pharmaceuticals U.S.A., Inc.
$287
TAIHO ONCOLOGY, INC.
$254
SOBI, INC
$251
NOVARTIS PHARMACEUTICALS CORPORATION
$250
ADC Therapeutics America, Inc.
$239
Bayer Healthcare Pharmaceuticals Inc.
$237
Pharmacyclics LLC, an AbbVie Company
$224
Kite Pharma, Inc.
$191
Stemline Therapeutics Inc.
$142
Merck Sharp & Dohme Corporation
$125
Genmab U.S., Inc.
$124
ADMA BioManufacturing LLC
$122
Rigel Pharmaceuticals, Inc.
$107
ARRAY BIOPHARMA INC
$106
Exelixis Inc.
$105
ABBVIE INC.
$104
Apellis Pharmaceuticals, Inc.
$102
EMD Serono, Inc.
$101
AbbVie Inc.
$96
Ipsen Biopharmaceuticals, Inc
$91
Acrotech Biopharma Inc.
$87
Myriad Genetic Laboratories, Inc.
$83
MorphoSys, US Inc.
$82
Myovant Sciences Inc.
$81
SANOFI-AVENTIS U.S. LLC
$78
Blueprint Medicines Corporation
$77
GENZYME CORPORATION
$76
Pharmacosmos Therapeutics Inc.
$76
Eisai Inc.
$74
G1 Therapeutics, Inc.
$69
Gilead Sciences, Inc.
$65
TG Therapeutics, Inc.
$65
Genentech USA, Inc.
$65
Heron Therapeutics, Inc.
$63
Taiho Oncology, Inc.
$62
Acceleron Pharma, Inc.
$59
Epizyme, Inc.,
$51
Tempus AI, Inc
$50
Sobi, Inc
$49
AVEO Pharmaceuticals, Inc.
$46
Coherus Biosciences Inc.
$46
GE HealthCare
$44
Deciphera Pharmaceuticals Inc.
$40
Helsinn Therapeutics (U.S.), Inc.
$39
Mirati Therapeutics, Inc.
$36
Karyopharm Therapeutics Inc.
$31
SpringWorks Therapeutics, Inc.
$30
CTI BioPharma Corp.
$28
Organon Llc
$25
Puma Biotechnology, Inc.
$24
Aveo Pharmaceuticals, Inc.
$23
PUMA BIOTECHNOLOGY, INC.
$22
ACCORD HEALTHCARE, INC.
$22
Dova Pharmaceuticals
$22
PharmaEssentia USA Corporation
$20
Tactile Systems Technology Inc
$18
Octapharma USA, Inc.
$17
Sun Pharmaceutical Industries Inc.
$14
SERVIER PHARMACEUTICALS LLC
$14
EISAI INC.
$13
Janssen Pharmaceuticals, Inc
$10
Top 3 companies account for 26.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AUGTYRO · AYVAKIT · BELEODAQ · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABOMETYX · CALQUENCE · CAMCEVI · CERDELGA · COSELA · CREON · CYRAMZA · Cresemba · DARZALEX · DOPTELET · Doptelet · ELREXFIO · ENHERTU · EPKINLY · ERBITUX · ERLEADA · EXKIVITY · Empaveli · Enhertu · Epkinly · FASLODEX · FOTIVDA · Fabhalta · Flexitouch Plus · GAVRETO · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · Non-Covered · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONGLYZA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · Padcev · Perjeta · Phesgo · Pomalyst · QINLOCK · Quzyttir · REBLOZYL · RETEVMO · RYBREVANT · Reblozyl · Rezlidhia · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SUSTOL · Stivarga · Sustol · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECVAYLI · TIBSOVO · TIVDAK · TRAZIMERA · TRUSELTIQ · TUKYSA · Tavalisse · Tazverik · Trodelvy · UKONIQ · Udenyca · VENCLEXTA · VERZENIO · VONJO · Vonjo · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · Zoladex · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (84%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for nurse practitioner - family in WA.
Geographic Context
Family nurse practitioners within 10 mi
729
Per 100K population
78.9
County median income
$96,632
Nearest hospital
ST JOSEPH MEDICAL CENTER
2.3 mi
2.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Retchless is a clinical cardiology specialist, with above-average Medicare volume (top 15% in WA), with low-engagement industry engagement in the top 1% of WA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Retchless experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Retchless performed 223 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Retchless receive payments from pharmaceutical companies?
Yes. Dr. Retchless received a total of $20,172 from 81 companies across 883 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Retchless's costs compare to other family nurse practitioners in Tacoma?
Dr. Retchless's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Retchless) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Family Nurse Practitioners in Tacoma
Browse family nurse practitioners in Tacoma ranked by procedure volume and transparency data.
Highest volume
Top Family Nurse Practitioners in WA
Family nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Nurse Practitioners in WA
Which WA family nurse practitioners receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology